Yousefnia S. Breast Cancer, Subtypes, Risk Factors, and Treatment. The Palgrave Encyclopedia of Disability: Springer; 2024. p. 1–14.
Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci. 2017;151:1–32.
Zhang YN, Xia KR, Li CY, Wei BL, Zhang B. Review of breast cancer pathologigcal image processing. Biomed Res Int. 2021;2021:1994764.
PubMed PubMed Central Google Scholar
Tsang JYS, Tse GM. Molecular classification of breast cancer. Adv Anat Pathol. 2020;27:27–35.
Ezzati M, Yousefi B, Velaei K, Safa A. A review on anti-cancer properties of Quercetin in breast cancer. Life Sci. 2020;248: 117463.
Fang L, Gao D, Wang T, Zhao H, Zhang Y, Wang S. From nature to clinic: Quercetin’s role in breast cancer immunomodulation. Front Immunol. 2024;15:1483459.
CAS PubMed PubMed Central Google Scholar
Kim H, Seo EM, Sharma AR, Ganbold B, Park J, Sharma G, et al. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells. Int J Oncol. 2013;43:1319–25.
Shan B-E, Wang M-X, R-qJCi Li. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/β-catenin signaling pathway. Cancer Invest. 2009;27:604–12.
Pahlke G, Ngiewih Y, Kern M, Jakobs S, Marko D, Eisenbrand G. Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells. J Agric Food Chem. 2006;54:7075–82.
Xiang T, Fang Y, Wang S-X. Quercetin suppresses HeLa cells by blocking PI3K/Akt pathway. J Huazhong Univ Sci Technol [Med Sci]. 2014;34:740–4.
Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M. The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res. 2006;26:1177–81.
Yuan Z, Long C, Junming T, Qihuan L, Youshun Z, Chan Z. Quercetin-induced apoptosis of HL-60 cells by reducing PI3K/Akt. Mol Biol Rep. 2012;39:7785–93.
Qin Y, He LY, Chen Y, Wang WY, Zhao XH, Wu MY. Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway. Xi bao yu fen zi mian yi xue za zhi = Chin J Cellular Mol Immunol. 2012;28(1):12–6.
Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res. 2012;318:925–35.
Mukherjee A, Khuda-Bukhsh AR. Quercetin down-regulates IL-6/STAT-3 signals to induce mitochondrial-mediated apoptosis in a nonsmall- cell lung-cancer cell line, A549. J Pharmacopuncture. 2015;18:19–26.
PubMed PubMed Central Google Scholar
Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, et al. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int. 2022;22:257.
CAS PubMed PubMed Central Google Scholar
Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004;279:27008–16.
Lee Y-K, Park OJ. Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol Rep. 2010;24:1493–7.
Tao S-f, He H-f, Chen Q. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells. Molecular and cellular biochemistry. Mol Cell Biochem. 2015;402:93–100.
Wei L, Liu T-T, Wang H-H, Hong H-M, Yu AL, Feng H-P, et al. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB. Breast Cancer Res. 2011;13:1–13.
Molani Gol R, Kheirouri S. The effects of quercetin on the apoptosis of human breast cancer cell lines MCF-7 and MDA-MB-231: a systematic review. Nutr Cancer. 2022;74:405–22.
Prieto-Vila M, Shimomura I, Kogure A, Usuba W, Takahashi RU, Ochiya T, et al. Quercetin inhibits lef1 and resensitizes docetaxel-resistant breast cancer cells. Molecules. 2020;25:2576.
CAS PubMed PubMed Central Google Scholar
Zhu Q, Yang L, Yang H, Han Y, Chen Y, He Y. Quercetin alleviates the progression of breast cancer-related depression via inhibiting the pyroptosis and promoting the immune response. Mediat Inflamm. 2022;2022:8011988.
Jiang J, Yang Y, Wang F, Mao W, Wang Z, Liu Z. Quercetin inhibits breast cancer cell proliferation and survival by targeting Akt/mTOR/PTEN signaling pathway. Chem Biol Drug Des. 2024;103: e14557.
Tsai K-W, Lo Y-H, Liu H, Yeh C-Y, Chen Y-Z, Hsu C-W, et al. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Mol Cancer. 2018;17:1–15.
Bentz AB. A Review of quercetin: chemistry, antioxident properties, and bioavailability. J Young Invest. 2017.
Chen WJ, Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH. Quercetin blocks the aggressive phenotype of triple-negative breast cancer by inhibiting IGF1/IGF1R-mediated EMT program. J Food Drug Anal. 2021;29:98–112.
CAS PubMed PubMed Central Google Scholar
Mariani C, Braca A, Vitalini S, De Tommasi N, Visioli F, Fico G. Flavonoid characterization and in vitro antioxidant activity of Aconitum anthora L.(Ranunculaceae). Phytochemistry. 2008;69:1220–6.
Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys. 2003;417:12–7.
D’Abrosca B, Pacifico S, Cefarelli G, Mastellone C, Fiorentino A. ‘Limoncella’apple, an Italian apple cultivar: phenolic and flavonoid contents and antioxidant activity. Food Chem. 2007;104:1333–7.
Rietveld A, Wiseman S. Antioxidant effects of tea: evidence from human clinical trials. J Nutr. 2003;133:3285S.
Sakanashi Y, Oyama K, Matsui H, Oyama TB, Oyama TM, Nishimura Y, et al. Possible use of quercetin, an antioxidant, for protection of cells suffering from overload of intracellular Ca2+: a model experiment. Life Sci. 2008;83:164–9.
Young IS, McEneny J. Lipoprotein oxidation and atherosclerosis. Biochem Soc Trans. 2001;29:358–62.
Kashyap D, Garg VK, Tuli HS, Yerer MB, Sak K, Sharma AK, et al. Fisetin and quercetin: promising flavonoids with chemopreventive potential. Biomolecules. 2019;9:174.
CAS PubMed PubMed Central Google Scholar
Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition. 2008;24:703–10.
Li X, Zhou N, Wang J, Liu Z, Wang X, Zhang Q, et al. Quercetin suppresses breast cancer stem cells (CD44(+)/CD24(-)) by inhibiting the PI3K/Akt/mTOR-signaling pathway. Life Sci. 2018;196:56–62.
Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999;54:960–3.
Golmohammadi M, Elmaghraby DA, Ramírez-Coronel AA, Rakhimov N, Mohammed SS, Romero-Parra RM, et al. A comprehensive view on the quercetin impact on bladder cancer: Focusing on oxidative stress, cellular, and molecular mechanisms. Fundam Clin Pharmacol. 2023;37:900–9.
Hu Y, Li R, Jin J, Wang Y, Ma R. Quercetin improves pancreatic cancer chemo-sensitivity by regulating oxidative-inflammatory networks. J Food Biochem. 2022;46: e14453.
Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol. 2024;98:1323–67.
Comments (0)